探索澳大利亚公众对抗生素治疗的偏好:一个离散选择实验。

IF 3.4 3区 医学 Q1 HEALTH CARE SCIENCES & SERVICES
Chris Degeling, Trent Yarwood, Alberto Nettel-Aguirre, Judy Mullan, Nina Reynolds, Gang Chen
{"title":"探索澳大利亚公众对抗生素治疗的偏好:一个离散选择实验。","authors":"Chris Degeling,&nbsp;Trent Yarwood,&nbsp;Alberto Nettel-Aguirre,&nbsp;Judy Mullan,&nbsp;Nina Reynolds,&nbsp;Gang Chen","doi":"10.1007/s40271-023-00640-z","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Identify Australian public preferences for antibiotic treatments in the context of antibiotic stewardship.</p><p><strong>Methods: </strong>A discrete choice experiment (DCE) was conducted in Australia to investigate the importance of seven attributes associated with antibiotic treatments and related stewardship practices: contribution to antimicrobial resistance (AMR), treatment duration, side effects, days needed to recover, days before taking antibiotics, treatment failure and out-of-pocket costs. The DCE data were analysed using conditional logit, mixed logit and latent class conditional logit models. The relative importance of each attribute was calculated.</p><p><strong>Results: </strong>A total of 1882 respondents completed the survey; the main study sample consist of 1658 respondents (mean age 48 years) who passed quality checks. All seven attributes significantly influenced respondents' preferences for antibiotic treatments. Based on the designed attribute levels in the DCE, on average, out-of-pocket costs (32.8%) and contribution to antibiotic resistance (30.3%) were the most important attributes, followed by side effects (12.9%). Days before starting medication was least important (3.9%). Three latent classes were identified. Class 1 (including respondents who were more likely to be older and more health literate; 24.5%) gave contribution to antibiotic resistance greater importance in treatment preferences. Class 2 (including respondents more likely to report poorer health; 25.2%) gave out-of-pocket costs greater importance. The remaining (50.4%), who were generally healthier, perceived side effects as the most important attribute.</p><p><strong>Conclusions: </strong>Despite concerted public awareness raising campaigns, our results suggest that several factors may influence the preferences of Australians when considering antibiotic use. However, for those more likely to be aware of the need to preserve antibiotics, out-of-pocket costs and limiting the contribution to antibiotic resistance are the dominant influence. Delays in starting treatment were not important for any latent class, suggesting public tolerance for this measure. These results could help inform strategies to promote prudent antibiotic stewardship.</p>","PeriodicalId":51271,"journal":{"name":"Patient-Patient Centered Outcomes Research","volume":null,"pages":null},"PeriodicalIF":3.4000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8f/9c/40271_2023_Article_640.PMC10409829.pdf","citationCount":"0","resultStr":"{\"title\":\"Exploring the Preferences of the Australian Public for Antibiotic Treatments: A Discrete Choice Experiment.\",\"authors\":\"Chris Degeling,&nbsp;Trent Yarwood,&nbsp;Alberto Nettel-Aguirre,&nbsp;Judy Mullan,&nbsp;Nina Reynolds,&nbsp;Gang Chen\",\"doi\":\"10.1007/s40271-023-00640-z\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>Identify Australian public preferences for antibiotic treatments in the context of antibiotic stewardship.</p><p><strong>Methods: </strong>A discrete choice experiment (DCE) was conducted in Australia to investigate the importance of seven attributes associated with antibiotic treatments and related stewardship practices: contribution to antimicrobial resistance (AMR), treatment duration, side effects, days needed to recover, days before taking antibiotics, treatment failure and out-of-pocket costs. The DCE data were analysed using conditional logit, mixed logit and latent class conditional logit models. The relative importance of each attribute was calculated.</p><p><strong>Results: </strong>A total of 1882 respondents completed the survey; the main study sample consist of 1658 respondents (mean age 48 years) who passed quality checks. All seven attributes significantly influenced respondents' preferences for antibiotic treatments. Based on the designed attribute levels in the DCE, on average, out-of-pocket costs (32.8%) and contribution to antibiotic resistance (30.3%) were the most important attributes, followed by side effects (12.9%). Days before starting medication was least important (3.9%). Three latent classes were identified. Class 1 (including respondents who were more likely to be older and more health literate; 24.5%) gave contribution to antibiotic resistance greater importance in treatment preferences. Class 2 (including respondents more likely to report poorer health; 25.2%) gave out-of-pocket costs greater importance. The remaining (50.4%), who were generally healthier, perceived side effects as the most important attribute.</p><p><strong>Conclusions: </strong>Despite concerted public awareness raising campaigns, our results suggest that several factors may influence the preferences of Australians when considering antibiotic use. However, for those more likely to be aware of the need to preserve antibiotics, out-of-pocket costs and limiting the contribution to antibiotic resistance are the dominant influence. Delays in starting treatment were not important for any latent class, suggesting public tolerance for this measure. These results could help inform strategies to promote prudent antibiotic stewardship.</p>\",\"PeriodicalId\":51271,\"journal\":{\"name\":\"Patient-Patient Centered Outcomes Research\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2023-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8f/9c/40271_2023_Article_640.PMC10409829.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Patient-Patient Centered Outcomes Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s40271-023-00640-z\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Patient-Patient Centered Outcomes Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s40271-023-00640-z","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

摘要

目的:在抗生素管理的背景下,确定澳大利亚公众对抗生素治疗的偏好。方法:在澳大利亚进行离散选择实验(DCE),调查与抗生素治疗和相关管理实践相关的七个属性的重要性:对抗菌素耐药性(AMR)的贡献、治疗持续时间、副作用、恢复所需天数、服用抗生素前天数、治疗失败和自付费用。DCE数据采用条件logit、混合logit和潜在类条件logit模型进行分析。计算每个属性的相对重要性。结果:共有1882名受访者完成了调查;主要研究样本包括1658名通过质量检查的受访者(平均年龄48岁)。所有七个属性都显著影响了受访者对抗生素治疗的偏好。根据DCE的设计属性水平,平均而言,自付费用(32.8%)和对抗生素耐药性的贡献(30.3%)是最重要的属性,其次是副作用(12.9%)。服药前天数最不重要(3.9%)。确定了三个潜在类别。第一类(包括更可能是老年人和更有健康知识的受访者;24.5%)认为抗生素耐药性在治疗选择中更重要。第2类(包括更有可能报告健康状况较差的受访者;25.2%)认为自付费用更为重要。其余(50.4%)的人总体更健康,认为副作用是最重要的因素。结论:尽管有一致的公众意识提高运动,我们的结果表明,几个因素可能会影响澳大利亚人在考虑使用抗生素时的偏好。然而,对于那些更有可能意识到需要保留抗生素的人来说,自付费用和限制对抗生素耐药性的贡献是主要影响。延迟开始治疗对任何潜在类型都不重要,这表明公众对这一措施的耐受性。这些结果可能有助于制定促进谨慎抗生素管理的策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Exploring the Preferences of the Australian Public for Antibiotic Treatments: A Discrete Choice Experiment.

Exploring the Preferences of the Australian Public for Antibiotic Treatments: A Discrete Choice Experiment.

Objectives: Identify Australian public preferences for antibiotic treatments in the context of antibiotic stewardship.

Methods: A discrete choice experiment (DCE) was conducted in Australia to investigate the importance of seven attributes associated with antibiotic treatments and related stewardship practices: contribution to antimicrobial resistance (AMR), treatment duration, side effects, days needed to recover, days before taking antibiotics, treatment failure and out-of-pocket costs. The DCE data were analysed using conditional logit, mixed logit and latent class conditional logit models. The relative importance of each attribute was calculated.

Results: A total of 1882 respondents completed the survey; the main study sample consist of 1658 respondents (mean age 48 years) who passed quality checks. All seven attributes significantly influenced respondents' preferences for antibiotic treatments. Based on the designed attribute levels in the DCE, on average, out-of-pocket costs (32.8%) and contribution to antibiotic resistance (30.3%) were the most important attributes, followed by side effects (12.9%). Days before starting medication was least important (3.9%). Three latent classes were identified. Class 1 (including respondents who were more likely to be older and more health literate; 24.5%) gave contribution to antibiotic resistance greater importance in treatment preferences. Class 2 (including respondents more likely to report poorer health; 25.2%) gave out-of-pocket costs greater importance. The remaining (50.4%), who were generally healthier, perceived side effects as the most important attribute.

Conclusions: Despite concerted public awareness raising campaigns, our results suggest that several factors may influence the preferences of Australians when considering antibiotic use. However, for those more likely to be aware of the need to preserve antibiotics, out-of-pocket costs and limiting the contribution to antibiotic resistance are the dominant influence. Delays in starting treatment were not important for any latent class, suggesting public tolerance for this measure. These results could help inform strategies to promote prudent antibiotic stewardship.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Patient-Patient Centered Outcomes Research
Patient-Patient Centered Outcomes Research HEALTH CARE SCIENCES & SERVICES-
CiteScore
6.60
自引率
8.30%
发文量
44
审稿时长
>12 weeks
期刊介绍: The Patient provides a venue for scientifically rigorous, timely, and relevant research to promote the development, evaluation and implementation of therapies, technologies, and innovations that will enhance the patient experience. It is an international forum for research that advances and/or applies qualitative or quantitative methods to promote the generation, synthesis, or interpretation of evidence. The journal has specific interest in receiving original research, reviews and commentaries related to qualitative and mixed methods research, stated-preference methods, patient reported outcomes, and shared decision making. Advances in regulatory science, patient-focused drug development, patient-centered benefit-risk and health technology assessment will also be considered. Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in The Patient may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand important medical advances. All manuscripts are subject to peer review by international experts.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信